Literature DB >> 27906685

Targeted chimera delivery to ovarian cancer cells by heterogeneous gold magnetic nanoparticle.

Yao Chen1, Mengjiao Xu, Yi Guo, Keyao Tu, Weimin Wu, Jianjun Wang, Xiaowen Tong, Wenjuan Wu, Lifeng Qi, Donglu Shi.   

Abstract

Efficient delivery of small interfering RNAs (siRNAs) to the targeted cells has remained a significant challenge in clinical applications. In the present study, we developed a novel aptamer-siRNA chimera delivery system mediated by cationic Au-Fe3O4 nanoparticles (NPs). The chimera constructed by VEGF RNA aptamer and Notch3 siRNA was bonded with heterogeneous Au-Fe3O4 nanoparticles by electrostatic interaction. The obtained complex exhibited much higher silencing efficiency against Notch3 gene compared with chimera alone and lipofectamine-siRNA complex, and improved the antitumor effects of the loaded chimera. Moreover, the efficient delivery of the chimera by Au-Fe3O4 NPs could reverse multi-drug resistance (MDR) of ovarian cancer cells against the chemotherapeutic drug cisplatin, indicating its potential capability for future targeted cancer therapy while overcoming MDR.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27906685     DOI: 10.1088/0957-4484/28/2/025101

Source DB:  PubMed          Journal:  Nanotechnology        ISSN: 0957-4484            Impact factor:   3.874


  8 in total

1.  A nanocomposite prepared from bifunctionalized ionic liquid, chitosan, graphene oxide and magnetic nanoparticles for aptamer-based assay of tetracycline by chemiluminescence.

Authors:  Yuanling Sun; Yuxue Dai; Xiaodong Zhu; Rui Han; Xueying Wang; Chuannan Luo
Journal:  Mikrochim Acta       Date:  2019-12-18       Impact factor: 5.833

Review 2.  Theranostic small interfering RNA nanoparticles in cancer precision nanomedicine.

Authors:  Zhihang Chen; Balaji Krishnamachary; Jesus Pachecho-Torres; Marie-France Penet; Zaver M Bhujwalla
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2019-10-23

3.  Recombinant elastin-based nanoparticles for targeted gene therapy.

Authors:  D A Monfort; P Koria
Journal:  Gene Ther       Date:  2017-09-14       Impact factor: 5.250

Review 4.  Recent Advances in the Development of Exogenous dsRNA for the Induction of RNA Interference in Cancer Therapy.

Authors:  Tatiana S Golubeva; Viktoria A Cherenko; Konstantin E Orishchenko
Journal:  Molecules       Date:  2021-01-29       Impact factor: 4.411

Review 5.  Aptamer Nanomaterials for Ovarian Cancer Target Theranostics.

Authors:  Jing Zhao; Wenxi Tan; Jingying Zheng; Yuanzhen Su; Manhua Cui
Journal:  Front Bioeng Biotechnol       Date:  2022-03-28

Review 6.  Donors for nerve transplantation in craniofacial soft tissue injuries.

Authors:  Sishuai Sun; Di Lu; Hanlin Zhong; Chao Li; Ning Yang; Bin Huang; Shilei Ni; Xingang Li
Journal:  Front Bioeng Biotechnol       Date:  2022-09-07

Review 7.  Insights on prospects of nano-siRNA based approaches in treatment of Cancer.

Authors:  Rajat Goyal; Hitesh Chopra; Inderbir Singh; Kamal Dua; Rupesh K Gautam
Journal:  Front Pharmacol       Date:  2022-08-25       Impact factor: 5.988

8.  Natural and artificial small RNAs: a promising avenue of nucleic acid therapeutics for cancer.

Authors:  Sunny Yadav; Mamta Shekhawat; Devashree Jahagirdar; Nilesh Kumar Sharma
Journal:  Cancer Biol Med       Date:  2017-08       Impact factor: 4.248

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.